36 related articles for article (PubMed ID: 27764516)
1. A Potential Role of CD82/KAI1 during Uterine Decidualization in Mice.
Li Q; Song M; Cao K; Zhang Q
Curr Issues Mol Biol; 2024 Feb; 46(3):1799-1809. PubMed ID: 38534734
[TBL] [Abstract][Full Text] [Related]
2. KAI1(CD82)-DARC(CD234) axis in the stem cell niche.
Hur J; Baek SH; Kim HS
Cell Cycle; 2016 Aug; 15(15):1945-7. PubMed ID: 27163847
[No Abstract] [Full Text] [Related]
3. Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer.
Reddi KK; Zhang W; Shahrabi-Farahani S; Anderson KM; Liu M; Kakhniashvili D; Wang X; Zhang YH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473906
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum metastasis suppressing compounds and therapeutic uses thereof in human tumors.
Komlosh PG; Chen JL; Childs-Disney J; Disney MD; Canaani D
Sci Rep; 2023 Nov; 13(1):20420. PubMed ID: 37990044
[TBL] [Abstract][Full Text] [Related]
5. The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma.
Zhu J; Liang C; Hua Y; Miao C; Zhang J; Xu A; Zhao K; Liu S; Tian Y; Dong H; Zhang C; Li P; Su S; Qin C; Wang Z
Oncotarget; 2017 Aug; 8(31):51559-51568. PubMed ID: 28881668
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel metastasis inducing lncRNA which suppresses the KAI1/CD82 metastasis suppressor gene and is upregulated in triple-negative breast cancer.
Aram R; Dotan I; Hotz-Wagenblatt A; Canaani D
Oncotarget; 2017 Sep; 8(40):67538-67552. PubMed ID: 28978052
[TBL] [Abstract][Full Text] [Related]
7. Reconstructing the molecular life history of gliomas.
Barthel FP; Wesseling P; Verhaak RGW
Acta Neuropathol; 2018 May; 135(5):649-670. PubMed ID: 29616301
[TBL] [Abstract][Full Text] [Related]
8. High LAMC1 expression in glioma is associated with poor prognosis.
Liu J; Liu D; Yang Z; Yang Z
Onco Targets Ther; 2019; 12():4253-4260. PubMed ID: 31213842
[No Abstract] [Full Text] [Related]
9. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
10. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
11. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj SN
J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the expression of KAI1/CD82 and PDGFRβ and their impact on glioma progression.
Paradowski M; Bilinska M; Bar J
Folia Neuropathol; 2016; 54(3):241-248. PubMed ID: 27764516
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
15. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
